您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
IL-28A/IFN-λ2 Protein, Mouse

IL-28A/IFN-λ2 Protein, Mouse

货号: UA040310
价格: 820
规格: 10μg
介绍: -
其他: -
产品规格
  • 物种

    Mouse
  • 分子别名

    Interferon lambda-2; IFN-lambda-2; Interleukin-28A (IL-28A)
  • Accession

    Q4VK74
  • 表达序列

    Asp20-Val193, with C-terminal 8*His

  • 表达宿主

    HEK293
  • 分子量

    25-30 kDa (Reducing)

  • 纯度

    >95% by SDS-PAGE and HPLC.
  • 内毒素含量

    <0.1EU/μg
  • 活性

    Test in progress.
  • 标记

    Unconjugated
  • 标签

    His Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 文献引用

    Nat Immunol. 2003 Jan;4(1):63-8. Epub 2002 Dec 2.

  • 稀释度

背景介绍
  • Interferon lambda 2 (IFN-λ2), also known as interleukin-28A (IL-28A), is a type III interferon that belongs to the interferon lambda family. IFN-λ2 is produced in response to viral infections and plays a crucial role in the innate immune response against viruses. It exerts antiviral effects by inducing the expression of interferon-stimulated genes (ISGs) that inhibit viral replication and spread. IFN-λ2 signals through the IFN-λ receptor complex, which consists of IL-10R2 and IL-28Rα subunits, leading to the activation of downstream signaling pathways involved in antiviral defense. IFN-λ2 is considered a promising therapeutic agent for the treatment of viral infections due to its potent antiviral properties and reduced potential for side effects compared to type I interferons.

  • 电泳JSON

    • 2μg (R: reducing condition, N: non-reducing condition).

  • 体积排阻色谱JSON(SEC-HPLC)

    • >95% as determined by SEC-HPLC.